Trial intelligence / Profile preview

Aerosolized Pentamidine vs SMX/TMP for PCP in AIDS

NCT00000715Phase 3Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of pentamidine in Pneumocystis pneumonia (PCP) (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.

02

Drugs

pentamidine
03

Conditions

Pneumocystis pneumonia (PCP)

Beyond the preview

Go deeper on NCT00000715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call